{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:50:24Z","timestamp":1790297424824,"version":"4.1.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Coexisting primary aldosteronism (PA) and subclinical Cushing's syndrome (SCS) caused by bilateral adrenocortical adenomas have occasionally been reported. Precise diagnosis and treatment of the disease pose a challenge to clinicians due to its atypical clinical manifestations and laboratory findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Summary<\/jats:title><jats:p>A 49-year-old woman was admitted to our hospital due to fatigue, increased nocturia and refractory hypertension. The patient had a history of severe left hydronephrosis 6 months prior. Laboratory examinations showed hypokalaemia (2.58 mmol\/L) and high urine potassium (71 mmol\/24 h). Adrenal computed tomography (CT) showed bilateral adrenal masses. Undetectable ACTH and unsuppressed plasma cortisol levels by dexamethasone indicated ACTH-independent Cushing's syndrome. Although the upright aldosterone-to-renin ratio (ARR) was 3.06 which did not exceed 3.7, elevated plasma aldosterone concentrations (PAC) with unsuppressed PAC after the captopril test still suggested PA. Adrenal venous sampling (AVS) without adrenocorticotropic hormone further revealed hypersecretion of aldosterone from the right side and no dominant side of cortisol secretion. A laparoscopic right adrenal tumor resection was performed. The pathological diagnosis was adrenocortical adenoma. After the operation, the supine and standing PAC were normalized; while the plasma cortisol levels postoperatively were still high and plasma renin was activated. The patient's postoperative serum potassium and 24-h urine potassium returned to normal without any pharmacological treatment. In addition, the patient's blood pressure was controlled normally with irbesartan alone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients with refractory hypertension should be screened for the cause of secondary hypertension. AVS should be performed in patients in which PA is highly suspected to determine whether there is the option of surgical treatment. Moreover, patients with PA should be screened for hypercortisolism, which can contribute to a proper understanding of the AVS result.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.911333","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T04:47:02Z","timestamp":1653886022000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case Report: Primary Aldosteronism and Subclinical Cushing Syndrome in a 49-Year-Old Woman With Hypertension Plus Hypokalaemia"],"prefix":"10.3389","volume":"9","author":[{"given":"Lihua","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieci","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Difei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2169\/internalmedicine.7778-21","article-title":"Primary aldosteronism presenting with hypertension five days after delivery: a case report and literature review","volume":"61","author":"Ohara","year":"2022","journal-title":"Intern Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/HJH.0b013e328360ddf6","article-title":"Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China","volume":"31","author":"Sang","year":"2013","journal-title":"J Hypertens."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2265.2011.04253.x","article-title":"Subclinical Cushing's syndrome: definition and management","volume":"76","author":"Terzolo","year":"2012","journal-title":"Clin Endocrinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"Therapy of endocrine disease: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12902-020-0490-0","article-title":"Clinical characterization of patients with primary aldosteronism plus subclinical Cushing's syndrome","volume":"20","author":"Yasuda","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"B7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00268-018-4788-2","volume":"43","author":"Acharya","year":"2019","journal-title":"Outcomes of adrenal venous sampling in patients with bilateral adrenal masses and ACTH-independent cushing's syndrome World J Surg."},{"key":"B8","first-page":"35","article-title":"A rare case of subclinical primary aldosteronism and subclinical cushing's syndrome without cardiovascular complications","volume":"41","author":"Kitajima","year":"2016","journal-title":"Tokai J Exp Clin Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.12998\/wjcc.v9.i5.1119","article-title":"Primary aldosteronism due to bilateral micronodular hyperplasia and concomitant subclinical Cushing's syndrome: a case report","volume":"9","author":"Teragawa","year":"2021","journal-title":"World J Clin Cases."},{"key":"B10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3904\/kjim.2014.29.5.679","article-title":"Aldosterone- and cortisol-co-producing adrenal adenoma without clinical features of Cushing's syndrome","volume":"29","author":"Chang","year":"2014","journal-title":"Korean J Intern Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1615\/JEnvironPatholToxicolOncol.2017021895","article-title":"Oncocytic adreno cortical tumors: pathological features of 16 cases and review of the literature","volume":"36","author":"Ertan","year":"2017","journal-title":"J Environ Pathol Toxicol Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.jacc.2020.02.055","article-title":"Primary aldosteronism in newly diagnosed hypertensive patients: lessons from China","volume":"75","author":"Funder","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"R191","DOI":"10.1530\/EJE-14-0537","article-title":"Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension","volume":"172","author":"Piaditis","year":"2015","journal-title":"Eur J Endocrinol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S2213-8587(17)30368-6","article-title":"Primary aldosteronism and cardiovascular risk, before and after treatment","volume":"6","author":"Funder","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-0031-1295438","article-title":"Prevalence of primary aldosteronism in patient's cohorts and in population-based studies\u2014a review of the current literature","volume":"44","author":"Hannemann","year":"2012","journal-title":"Horm Metab Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S2213-8587(14)70069-5","article-title":"Adrenal vein sampling in primary aldosteronism: towards a standardised protocol","volume":"3","author":"Monticone","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-019-0395-y","article-title":"Hypercortisolism and primary aldosteronism caused by bilateral adrenocortical adenomas: a case report","volume":"19","author":"Ren","year":"2019","journal-title":"BMC Endocr Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13256-020-2353-8","article-title":"Primary aldosteronism concurrent with subclinical Cushing's syndrome: a case report and review of the literature","volume":"14","author":"Zhang","year":"2020","journal-title":"J Med Case Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s00268-007-9332-8","article-title":"The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses","volume":"32","author":"Young","year":"2008","journal-title":"World J Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ecl.2018.01.003","article-title":"Recent advances on subclinical hypercortisolism","volume":"47","author":"Zavatta","year":"2018","journal-title":"Endocrinol Metab Clin North Am."}],"updated-by":[{"DOI":"10.3389\/fcvm.2022.1055119","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000}}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.911333\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T16:43:08Z","timestamp":1667493788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.911333\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":24,"alternative-id":["10.3389\/fcvm.2022.911333"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.911333","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fcvm.2022.1055119","asserted-by":"object"}]},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]},"article-number":"911333"}}